The effectiveness allows selling shareholders to immediately sell their shares into the market, creating severe dilution pressure. Monitor for any registered sales or further equity issuances. The going concern opinion amplifies downside risk.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 13 $6.63entry
- T+1 · 6mo ago −0.53%α −1.31% · $6.60
- T+5 · 6mo ago −3.47%α −2.31% · $6.40
- T+20 · 5mo ago +2.56%α +3.18% · $6.80
- T+60 · 3mo ago +15.91%α +11.47% · $7.69
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
The SEC declared effective Lifeward's Form S-3 registration statement (File 333-295352) filed on April 27, 2026. This shelf registration covers 7,256,474 ordinary shares held by selling shareholders Oramed Pharmaceuticals and Creative Value Capital LP, representing approximately 261% of current shares outstanding. The company receives no proceeds and its auditor has expressed substantial doubt about its ability to continue as a going concern.
Key Facts
- EFFECT notice for Form S-3 (333-295352) effective May 12, 2026
- S-3 registers 7,256,474 ordinary shares for resale by Oramed Pharmaceuticals and Creative Value Capital LP
- Resale shares represent ~261% of current shares outstanding ($18M market cap)
- Lifeward receives no proceeds from the resale offering
- Auditor has raised substantial doubt about going concern
Financial Impact
Potential overhang of 261% of shares outstanding; no proceeds to company
Risk Factors
- Massive dilution from selling shareholder overhang
- Going concern uncertainty
- Further equity issuances possible
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001589 |
| Document: 9999999995-26-001589-index.html | 9999999995-26-001589 |
| Document: 9999999995-26-001589.txt | 9999999995-26-001589 |
Track record
25 reports on LFWD
6 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +20.27% at T+60 after the Aug 14, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 13, 20263d ago Press Release Bearish 6/10 Entry $4.06 Now $3.62 +10.84% settles Nov 20
- Nov 12, 20264d ago 3 Neutral 1/10 Entry $4.06 Now $3.62 −10.84% settles Nov 20
- Nov 3, 202613d ago 3 Neutral 2/10 Entry $6.06 to $5.76 Now $3.62 −40.26% ▼ −4.95% −4.04% vs SPY
- Oct 27, 202620d ago 8-K Neutral 2/10 Entry $6.04 to $5.83 Now $3.62 −40.07% ▼ −3.48% −1.49% vs SPY
- Oct 8, 20265w ago 8-K Bearish 5/10 Entry $6.49 to $6.00 Now $3.62 +44.22% ▲ +7.55% +5.58% vs SPY
- Oct 1, 20266w ago 8-K Neutral 2/10 Entry $5.96 to $6.43 Now $3.62 −39.26% ▲ +7.89% +6.58% vs SPY
- Sep 25, 20267w ago DEF 14A Bearish 7/10 Entry $6.92 to $6.67 Now $3.62 +47.69% ▲ +3.61% +4.82% vs SPY
- Aug 14, 202613w ago 8-K Mixed 6/10 No price data
- Aug 14, 202613w ago Press Release Bearish 6/10 Entry $7.45 to $7.32 Now $3.62 +51.41% ▲ +1.75% +0.38% vs SPY
- Aug 11, 202614w ago EFFECT Bearish 7/10 Entry $7.57 to $7.41 Now $3.62 +52.15% ▲ +2.08% +1.67% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers